Effects of some synthetic kynurenines on brain amino acids and nitric oxide after pentylenetetrazole administration to rats

Journal of Pineal Research

Volumn 36, Issue 4, 2004, Pages 267-277

  Bikjdaouene, Leila ^a   Escames, Germaine ^a   Camacho, Encarnación ^b   Leon, Josefa ^a   Ferrer, José M R ^a   Espinosa, Antonio ^b   Gallo, Miguel A ^b   De Dios Luna, Juan ^a   Acuña Castroviejo, Darío ^a,c  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Excitatory amino acids; Inhibitory amino acids; Kynurenines; Nitric oxide; Pentylenetetrazole; Rats; Seizures

Indexed keywords

2 ACETAMIDO 4 (2 AMINO 5 METHOXYPHENYL) 4 OXOBUTYRIC ACID; 2 ACETAMIDO 4 (3 METHOXYPHENYL) 4 OXOBUTYRIC ACID; 2 BUTYRAMIDO 4 (2 AMINO 5 METHOXYPHENYL) 4 OXOBUTYRIC ACID; 2 BUTYRAMIDO(3 METHOXYPHENYL) 4 OXOBUTYRIC ACID; AMINO ACID DERIVATIVE; ANTICONVULSIVE AGENT; GLUTAMIC ACID; GLUTAMINE; KYNURENINE; NITRIC OXIDE; NITRITE; SERINE; TAURINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG SYNTHESIS; LATENT PERIOD; NONHUMAN; RAT; SEIZURE; SURVIVAL RATE;

AMINO ACIDS; ANIMALS; ANTICONVULSANTS; BRAIN; CONVULSANTS; KYNURENINE; MALE; NITRIC OXIDE; PENTYLENETETRAZOLE; RATS; SEIZURES;

EID: 1942531965     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00127.x     Document Type: Article

References (52)

1. WOLFGANG L. Animal models of intractable epilepsy. Prog Neurobiol 1997; 53:239-258.
2. LIPTON SA, ROSENBERG PA. Mechanisms of disease: excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330:613-622.
3. SEJIMA H, ITO M, KISHI K, TSUDA H, SHIRAISHI H. Regional excitatory and inhibitory amino acid concentrations in pentilenetetrazole kindling and kindled rat brain. Brain Develop 1997; 19:171-175.
4. VELÍSEK L, KUBOVÁ H, MARES P, VACHOVÁ D. Kainate/AMPA receptor antagonists are anticonvulsant against the tonic hindlimb component of pentylenetetrazol-induced seizures in developing rats. Pharmacol Biochem Behav 1995; 51:153-158.
5. SNYDER S. Nitric oxide: first in a new class of neurotransmitter. Science 1992; 257:494-496.
6. REITER RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12:151-180.
7. ACUÑA-CASTROVIEJO D, ESCAMES G, MACÍAS M et al. Cell protective role of melatonin in the brain. J Pineal Res 1995; 19:57-63.
8. MUÑOZ-HOYOS A, MOLINA-CARBALLO A, MACÍAS M et al. Comparison between tryptophan methoxyindole and kynurenine metabolic pathway in normal and preterm neonates and in neonates with acute fetal distress. Eur J Endocrinol 1998; 139:89-95.
9. BIKJDAOUENE L, ESCAMES G, LEON J et al. Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole- induced seizures. J Pineal Res 2003; 35:54-60.
10. SWARTZ KJ, DURING MJ, FREESE A, BEAL MF. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 1990; 10:2965-2973.
11. SCHWARCZ R. Melatonin and function of brain kynurenines. Biochem Soc Trans 1993; 21:77-82.
12. STONE TW. Development and therapeutic potential of kynurenic acids and kynurenine derivatives for neuroprotection. Trends Pharmacol Sci 2000; 21:149-154.
13. LEÓN J, VIVES F, CRESPO E et al. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenin derivatives. J Neuroendocrinol 1998; 10:297-302.
14. LEÓN J, VIVES F, GOMEZ I et al. Modulation of rat striatal glutamatergic response in search for new neuroprotective agent: evaluation of melatonin and some kynurenine derivatives. Brain Res Bull 1998; 45:525-530.
15. LEÓN J, MACÍAS M, ESCAMES G et al. Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines. Mol Pharmacol 2000; 58:967-975.
16. CAMACHO E, LEÓN J, CARRIÓN A et al. Inhibition of nNOS activity in rat brain by synthetic kynurenines: structure-activity dependent. J Med Chem 2002; 45:263-274.
17. ROCHA L, BRIONES M, ACKERMANN RF et al. Pentylenetetrazol-induced kindling: early involvement of excitatory and inhibitory systems. Epilepsy Res 1996; 26:105-113.
18. CORDA MG, GIORGI O, LONGONI B, ORLANDI M, BIGGIO G. Decrease in the function of the gamma-aminobutyric acid-coupled chloride channel produced by repeated administration of pentylenetetrazol to rats. J Neurochem 1990; 55:1216-1221.
19. RACINE RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972; 32:281-294.
20. PAXINOS G, WATSON C. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, 1982.
21. SOTO-OTERO R, MÉNDEZ-ALVAREZ E, GALÁN-VALIENTE J, AGUILAR-VEIGA E, SIERRA-MARCUÑO G. Quantitative analysis of neuroactive amino acids in brain tissue by liquid chromatography using fluorescent pre-column labelling with o-phthalaldehyde and N-acetyl-L-cysteine. Biomed Chromat 1994; 8:114-118.
22. COBO M, EXPÓSITO I, PORRAS A, MORA F. Release of amino acid neurotransmitters in different cortical areas of conscious adult and aged rats. Neurobiol Aging 1992; 16:705-709.
23. LOWRY OH, ROSENBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
24. GREEN LC, RUIZ DE LUZURIAGA K, WAGNER DA. Nitrite biosynthesis in man. Proc Natl Sci USA 1981; 78:7764-7768.
25. PEREIRA VA, MARESCAUX C, NEHLIG A. Age-dependent regulation of seizure activity by nitric oxide in the developing rat. Develop Brain Res 1998; 107:315-319.
26. LAPIN IP. Stimulant and convulsive effects of kynurenines injected into brain ventricle in mice. J Neural Transm 1978; 42:37-43.
27. ANDERSON WW, SWARTZWELDER HS, WILSON WA. The NMDA receptor antagonist 2-amino-5-phosphonovalerate blocks stimulus train-induced epileptogenesis but not epileptiform bursting in the rat hippocampal slice. J Neurophysiol 1987; 57:1-21.
28. BLECK TP, KLAWANS HL. Convulsive disorder: mechanisms of epilepsy and anticonvulsant action. In: Textbook of Clinical Neuropharmacology and Therapeutics. KLAWANS HL ed., Raven Press, New York, 1987; pp. 23-30.
29. MELDRUM B. Neurotransmitter amino acids in epilepsy. Electroencephalography and Clin Neurophysiol 1987; 39:191-199.
30. MELDRUM B, MILLAN M, PATEL S, DE SARRO G. Anti-epileptic effects of focal microinjection of excitatory amino acid antagonist. J Neural Transm 1988; 72:191-200.
31. RAMANJANEYULU R, TICKU M. Interactions of pentamethylene-tetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. Eur J Pharmacol 1984; 98:337-345.
32. BASHKATOVA V, VITSKOVA G, NARKEVICH V, VANIN A, MIKOYAN V, RAYEVSKY K. Nitric oxide content measured by ESR-spectroscopy in the rat brain is increased during pentylenetetrazole-induced seizures. J Mol Neurosci 2000; 14:183-190.
33. SAVIC I, PERSSON A, ROLAND P, PAULI S, SADVALL G, WINDEN L. In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988; 8616:863-866.
34. TREIMAN DM. GABAergic mechanisms in epilepsy. Epilepsia 2000; 42:8-12.
35. TUFF LP, RACINE RJ, MISHRA RK. The effects of kindling on GABA-mediated inhibition in the dentate gyrus of the rat II. Receptor binding. Brain Res 1983; 277:91-98.
36. PERKINS MN, STONE TW. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 1982; 247:184-187.
37. SCHARFMAN HE, GOODMAN JH. Effects of central and peripheral administration of kynurenic acid on hippocampal evoked responses in vivo and in vitro. Neuroscience 1998; 86:751-764.
38. LAPIN IP. Nicotinamide, inosine and hypoxantine, putative endogenous ligands of the benzodiazepine receptor, opposite to diazepan are much more effective against kynurenine-induced seizures than against pentylenetetrazol- induced seizures. Pharmacol Biochem Behav 1981; 14:589-593.
39. MUÑOZ-HOYOS A, MOLINA-CARBALLO A, RODRÍGUEZ-CABEZAS T, UBEROS-FERNÁNDEZ J, RUIZ-COSANO C, ACUÑA-CASTROVIEJO D. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures. Clin Endocrinol 1997; 47:667-677.
40. ESCAMES G, MACÍAS M, LEÓN J et al. Calcium-dependent effects of melatonin inhibition of glutamatergic response in rat striatum. J Neuroendocrinol 2001; 13:459-466.
41. BREDT DS, SNYDER SH. Nitric oxide, a novel neuronal messenger. Neuron 1992; 8:3-11.
42. ALAGARSAMY S, LONART G, JOHNSON KM. Regulation of nitric oxide synthase activity in cortical slices by excitatory amino acids and calcium. J Neurosci Res 1994; 38:648-653.
43. DAWSON VL, DAWSON TM, BARTLEY DA, UHL GR, SNYDER SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci 1993; 13:2651-2661.
44. DAWSON VL, DAWSON TM, LONDON ED, BREDT DS, SNYDER SH. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 1991; 88:6368-6371.
45. HAN D, YAMADA K, SENZAKI K, XIONG H, NAWA H, NABESHIMA T. Involvement of nitric oxide in pentylenetetrazole-induced kindling in rats. J Neurochem 2000; 74:792-798.
46. DE VASCONCELOS AP, GIZARD F, MARESCAUX C, NEHLIG A. Role of nitric oxide ion pentylenetetrazol-induced seizures: age-dependent effects in the immature rat. Epilepsia 2000; 41:363-371.
47. RESMEYER AR, MAYO JC, ZELOSKO V et al. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. J Pineal Res 2003; 8:205-213.
48. GILAD E, CUZZOCREA S, ZINGARELLI B, SALZMAN AL, SZABÓ C. Melatonin is a scavenger of peroxynitrine. Life Sci 1997; 60:169-174.
49. BLANCHARD-FILLION B, SERVY C, DUCROCQ C. 1-Nitrosome-latonin is a spontaneous NO-releasing compound. Free Radic Res 2001; 35:857-866.
50. REITER RJ, TAN DX, BURKHARDT S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 2002; 123:1007-1019.
51. JELENKOVIC A, JOVANOVIC M, NINKOVIC M, MAKSIMOVIC M, BOKONJIC D, BOSKOVIC B. Nitric oxide (NO) and convulsions induced by pentylenetetrazol. Ann NY Acad Sci 2002; 962:296-305.
52. BOROWICZ KK, LUSZCZKI J, KLEINROK Z, CZUCZWAR SJ. 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J Neural Transm 2000; 107:1117-1126.